DAX22.513 -0,4%ESt505.493 -0,1%Top 10 Crypto14,91 +4,4%Dow44.546 -0,4%Nas20.027 +0,4%Bitcoin92.458 -0,6%Euro1,0492 ±-0,0%Öl74,64 -0,9%Gold2.884 ±0,0%

1 Aktie gratis Trading Krypto kaufen^* ETF-Sparplan

Diaxonhit Aktie

NeuKaufen Kaufen Verkaufen Verkaufen

25,25 EUR -0,05 EUR -0,20 %

14.02.2025

STU

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Smartphone

Marktkap.254,64 Mio. EUR

KGV37,97Div. Rendite0,00%

WKNA2DVTN

ISINFR0013240934

SymbolDXNHF

Werbung

Diaxonhit Aktien News

Sortieren:Datum Meistgelesen

19.12.24GlobeNewswireEurobio Scientific: EB Development obtains a significant majority of the capital with 88.9% held at the end of the Reopened Offer to continue its development with NextStage AM and IK Partners

24.09.24GlobeNewswireEurobio Scientific: RESULTS FOR THE 1ST HALF OF 2024

02.08.24GlobeNewswireEUROBIO SCIENTIFIC COMPLETES ACQUISITION OF ENDOPREDICT® GENOMIC TEST FROM MYRIAD GENETICS

WerbungDiaxonhit-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

31.07.24GlobeNewswireEUROBIO SCIENTIFIC: CONCLUSION OF AN AGREEMENT BETWEEN EUROBIO SCIENTIFIC AND A CONSORTIUM LED BY EUROBIO SCIENTIFIC'S TEAM OF ENTREPRENEURS AND MANAGERS, IK PARTNERS AND NEXTSTAGE AM WITH A VIEW TO F

31.07.24GlobeNewswireEurobio Scientific: FIRST HALF 2024, A SOLID START TO THE FINANCIAL YEAR IN AN UNCERTAIN ENVIRONMENT // PROPOSED TENDER OFFER

07.05.24GlobeNewswireEUROBIO SCIENTIFIC SIGNS AN AGREEMENT TO ACQUIRE GENE EXPRESSION TEST FOR BREAST CANCER ENDOPREDICT®

10.04.24GlobeNewswireEUROBIO SCIENTIFIC: 2023 ANNUAL RESULTS

30.01.24GlobeNewswireEurobio Scientific: FISCAL YEAR 2023, STRATEGIC TRANSFORMATION OF THE GROUP

07.11.23GlobeNewswireEurobio Scientific: CATHERINE COURBOILLET TO JOIN EUROBIO SCIENTIFIC BOARD AS AN INDEPENDENT MEMBER

30.10.23GlobeNewswireEurobio Scientific - MISE À DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2023

17.10.23GlobeNewswireEurobio Scientific: GenDx reduces organ matching time to 3 hours

11.10.23GlobeNewswireEurobio Scientific : Results for the First Half of 2023

24.07.23GlobeNewswireEUROBIO : ACCELERATION OF STRATEGIC DEPLOYMENT IN THE FIRST HALF OF 2023

11.07.23GlobeNewswireEurobio Scientific: Capital reduction through cancellation of treasury shares

16.06.23GlobeNewswireEurobio Scientific: all resolutions approved at the Annual General Meeting

13.06.23GlobeNewswireEurobio Scientific continues its international development with the acquisition of DID in Italy, Europe's third largest diagnostics market

23.05.23GlobeNewswireEurobio Scientific becomes one of the first European companies to obtain IVDR1 CE marking of PCR tests

05.04.23GlobeNewswireEurobio Scientific : 2022 ANNUAL RESULTS - Very strong performance and strengthening of the Core Business

14.02.23GlobeNewswireEurobio Scientific: Wietse Mulder, CEO of GenDx, holds a 2% stake

Werbung

Diaxonhit News

Diaxonhit News: auf dieser Seite finden Sie alle Diaxonhit News und Nachrichten zur Diaxonhit Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Diaxonhit News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Diaxonhit News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.